Loading...
Successful Treatment of Castleman’s Disease with Interleukin-1 Receptor Antagonist (Anakinra)
Castleman’s disease (CD) is a very rare lymphoproliferative disorder whose underlying pathophysiology is not fully understood and for which no standard treatment exists. Because interleukin-1 (IL-1) might promote the production of interleukin-6 (IL-6), a key pathogenic factor for the disease, we hyp...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2010
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3108331/ https://ncbi.nlm.nih.gov/pubmed/20501803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-10-0156 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|